Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 158

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Early-onset and delayed-onset poststroke dementia — revisiting the mechanisms

Mok, Vincent C. T., Lam, Bonnie Y. K., Wong, Adrian, Ko, Ho, Markus, Hugh S., Wong, Lawrence K. S.·2017·Nature Reviews Neurology
DOI 10.1038/nrneurol.2017.16
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nrneurol.2017.16

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 34 references

Research works printed but not linked: 95

  1. Desmond, D. W., Moroney, J. T., Sano, M. & Stern, Y. Mortality in patients with dementia after ischemic stroke. Neurology 59, 537–543 (2002). · DOI
  2. Mok, V. C. et al. Delayed-onset dementia after stroke or transient ischemic attack. Alzheimers Dement. 12, 1167–1176 (2016). · DOI
  3. Srikanth, V. K., Quinn, S. J., Donnan, G. A., Saling, M. M. & Thrift, A. G. Long-term cognitive transitions, rates of cognitive change, and predictors of incident dementia in a population-based first-ever stroke cohort. Stroke 37, 2479–2483 (2006). · DOI · Paper page
  4. Altieri, M. et al. Delayed poststroke dementia: a 4-year follow-up study. Neurology 62, 2193–2197 (2004). · DOI
  5. Desmond, D. W., Moroney, J. T., Sano, M. & Stern, Y. Incidence of dementia after ischemic stroke: results of a longitudinal study. Stroke 33, 2254–2262 (2002). · DOI · Paper page
  6. Diener, H. C. et al. Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the prevention regimen for effectively avoiding second strokes (PROFESS) trial: a double-blind, active and placebo-controlled study. Lancet Neurol. 7, 875–884 (2008). · DOI · Paper page
  7. Pearce, L. A. et al. Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial. Lancet Neurol. 13, 1177–1185 (2014). · DOI · Paper page
  8. Tzourio, C. et al. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch. Intern. Med. 163, 1069–1075 (2003). · DOI · Paper page
  9. Pendlebury, S. T. Dementia in patients hospitalized with stroke: rates, time course, and clinico-pathologic factors. Int. J. Stroke 7, 570–581 (2012). · DOI
  10. Barba, R. et al. Poststroke dementia: clinical features and risk factors. Stroke 31, 1494–1501 (2000). · DOI · Paper page
  11. Zhou, D. D. et al. Study on frequency and predictors of dementia after ischemic stroke. J. Neurol. 251, 421–427 (2004). · DOI
  12. Munsch, F. et al. Stroke location is an independent predictor of cognitive outcome. Stroke 47, 66–73 (2016). · DOI
  13. Tatemichi, T. K. et al. Confusion and memory loss from capsular genu infarction: a thalamocortical disconnection syndrome? Neurology 42, 1966–1979 (1992). · DOI · Paper page
  14. Liao, D. et al. The prevalence and severity of white matter lesions, their relationship with age, ethnicity, gender, and cardiovascular disease risk factors: the ARIC study. Neuroepidemiology 16, 149–162 (1997). · DOI · Paper page
  15. Wong, A. et al. Relations between recent past leisure activities with risks of dementia and cognitive functions after stroke. PLoS ONE 11, e0159952 (2016). · DOI
  16. Wardlaw, J. et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 12, 822–838 (2013). · DOI · Paper page
  17. Wang, Z. et al. Risk factors and cognitive relevance of cortical cerebral microinfarcts in patients with ischemic stroke or transient ischemic attack. Stroke 47, 2450–2455 (2016). · DOI
  18. Mok, V. et al. Race-ethnicity and cerebral small vessel disease — comparison between Chinese and White populations. Int. J. Stroke 9, 36–42 (2014). · DOI
  19. Liu, W., Wong, A., Law, A. C. K. & Mok, V. C. T. Cerebrovascular disease, amyloid plaques, and dementia. Stroke 46, 1402–1407 (2015). · DOI
  20. Yang, J. et al. Risk factors for incident dementia after stroke and transient ischemic attack. Alzheimers Dement. 11, 16–23 (2015). · DOI · Paper page
  21. Jansen, W. et al. Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. JAMA 313, 1924–1938 (2015). · DOI · Paper page
  22. Norton, S., Matthews, F. E., Barnes, D. E., Yaffe, K. & Brayne, C. Potential for primary prevention of Alzheimer's disease: an analysis of population-based data. Lancet Neurol. 13, 788–794 (2014). · DOI · Paper page
  23. Whitehead, S. N., Cheng, G., Hachinski, V. C. & Cechetto, D. F. Progressive increase in infarct size, neuroinflammation, and cognitive deficits in the presence of high levels of amyloid. Stroke 38, 3245–3250 (2007). · DOI
  24. Silbert, L. C. et al. Trajectory of white matter hyperintensity burden preceding mild cognitive impairment. Neurology 79, 741–747 (2012). · DOI
  25. Wen, H. M. et al. Effect of white matter changes on cognitive impairment in patients with lacunar infarcts. Stroke 35, 1826–1830 (2004). · DOI
  26. Dey, A. K., Stamenova, V., Turner, G., Black, S. E. & Levine, B. Pathoconnectomics of cognitive impairment in small vessel disease: a systematic review. Alzheimers Dement. 12, 831–845 (2016). · DOI
  27. Mok, V. et al. Predictors for cognitive decline in patients with confluent white matter hyperintensities. Alzheimers Dement. 8, S96–S103 (2012). · DOI
  28. van der Flier, W. M. et al. Small vessel disease and general cognitive function in nondisabled elderly: the LADIS study. Stroke 36, 2116–2120 (2005). · DOI · Paper page
  29. Wang, Z. et al. Cerebral microbleeds and cognitive function in ischemic stroke or transient ischemic attack patients. Dement. Geriatr. Cogn. Disord. 40, 130–136 (2015). · DOI
  30. Willette, A. A. et al. Insulin resistance, brain atrophy, and cognitive performance in late middle-aged adults. Diabetes Care 36, 443–449 (2013). · DOI · Paper page
  31. Roberts, R. O. et al. Diabetes and elevated hemoglobin a1c levels are associated with brain hypometabolism but not amyloid accumulation. J. Nucl. Med. 55, 759–764 (2014). · DOI · Paper page
  32. Poggesi, A., Inzitari, D. & Pantoni, L. Atrial fibrillation and cognition: epidemiological data and possible mechanisms. Stroke 46, 3316–3321 (2015). · DOI
  33. Adib-Samii, P., Brice, G., Martin, R. J. & Markus, H. S. Clinical spectrum of cadasil and the effect of cardiovascular risk factors on phenotype study in 200 consecutively recruited individuals. Stroke 41, 630–634 (2010). · DOI · Paper page
  34. Tang, W. K. et al. Frequency and determinants of poststroke dementia in Chinese. Stroke 35, 930–935 (2004). · DOI
  35. Reitz, C., Bos, M. J., Hofman, A., Koudstaal, P. J. & Breteler, M. M. Prestroke cognitive performance, incident stroke, and risk of dementia: the Rotterdam study. Stroke 39, 36–41 (2008). · DOI
  36. Srikanth, V. K. et al. Progressive dementia after first-ever stroke: a community-based follow-up study. Neurology 63, 785–792 (2004). · DOI
  37. Mohan, K. M. et al. Risk and cumulative risk of stroke recurrence: a systematic review and meta-analysis. Stroke 42, 1489–1494 (2011). · DOI · Paper page
  38. Sahathevan, R. et al. Positron emission tomographic imaging in stroke: cross-sectional and follow-up assessment of amyloid in ischemic stroke. Stroke 47, 113–119 (2016). · DOI
  39. Wollenweber, F. A. et al. Prevalence of amyloid positron emission tomographic positivity in poststroke mild cognitive impairment. Stroke 47, 2645–2648 (2016). · DOI
  40. Liu, W. et al. Influence of amyloid-β on cognitive decline after stroke/transient ischemic attack: three-year longitudinal study. Stroke 46, 3074–3080 (2015). · DOI
  41. Ossenkoppele, R. et al. Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis. JAMA 313, 1939–1949 (2015). · DOI · Paper page
  42. Fodero-Tavoletti, M. T. et al. 18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease. Brain 134, 1089–1100 (2011). · DOI · Paper page
  43. Okamura, N. et al. Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET. Brain 137, 1762–1771 (2014). · DOI · Paper page
  44. Humpel, C. Chronic mild cerebrovascular dysfunction as a cause for Alzheimer's disease? Exp. Gerontol. 46, 225–232 (2011). · DOI
  45. Hénon, H. et al. Poststroke dementia: incidence and relationship to prestroke cognitive decline. Neurology 57, 1216–1222 (2001). · DOI · Paper page
  46. Dufouil, C. et al. Severe cerebral white matter hyperintensities predict severe cognitive decline in patients with cerebrovascular disease history. Stroke 40, 2219–2221 (2009). · DOI · Paper page
  47. Verdelho, A. et al. White matter changes and diabetes predict cognitive decline in the elderly: the LADIS study. Neurology 75, 160–167 (2010). · DOI · Paper page
  48. Lawrence, A. J. et al. Pattern and rate of cognitive decline in cerebral small vessel disease: a prospective study. PLoS ONE 10, e0135523 (2015). · DOI
  49. Hong, Y. J. et al. Do Alzheimer's disease (AD) and subcortical ischemic vascular dementia (SIVD) progress differently? Arch. Gerontol. Geriatr. 58, 415–419 (2014). · DOI
  50. Brookes, R. L., Hollocks, M. J., Khan, U., Morris, R. G. & Markus, H. S. The brief memory and executive test (BMET) for detecting vascular cognitive impairment in small vessel disease: a validation study. BMC Med. 13, 51 (2015). · DOI
  51. Doyle, K. P. et al. B-lymphocyte-mediated delayed cognitive impairment following stroke. J. Neurosci. 35, 2133–2145 (2015). · DOI · Paper page
  52. de Bruijn, R. & Ikram, M. Cardiovascular risk factors and future risk of Alzheimer's disease. BMC Med. 12, 130 (2014). · DOI · Paper page
  53. Forette, F. et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 352, 1347–1351 (1998). · DOI · Paper page
  54. Koton, S. et al. Stroke incidence and mortality trends in us communities, 1987 to 2011. JAMA 312, 259–268 (2014). · DOI · Paper page
  55. Feigin, V. L. et al. 30-year trends in stroke rates and outcome in Auckland, New Zealand (1981–2012): a multi-ethnic population-based series of studies. PLoS ONE 10, e0134609 (2015). · DOI
  56. Wu, Y. T. et al. Dementia in western Europe: epidemiological evidence and implications for policy making. Lancet Neurol. 15, 116–124 (2016). · DOI · Paper page
  57. Langa, K. M. et al. A comparison of the prevalence of dementia in the United States in 2000 and 2012. JAMA Intern. Med. 177, 51–58 (2016). · DOI · Paper page
  58. Kovari, E., Herrmann, F. R., Bouras, C. & Gold, G. Amyloid deposition is decreasing in aging brains: an autopsy study of 1,599 older people. Neurology 82, 326–331 (2014). · DOI
  59. Johnsen, S. P. et al. Preadmission oral anticoagulant treatment and clinical outcome among patients hospitalized with acute stroke and atrial fibrillation: a nationwide study. Stroke 45, 168–175 (2014). · DOI
  60. Choi, J. C. et al. Effect of pre-stroke statin use on stroke severity and early functional recovery: a retrospective cohort study. BMC Neurol. 15, 120 (2015). · DOI
  61. Park, J. M. et al. Comparative effectiveness of prestroke aspirin on stroke severity and outcome. Ann. Neurol. 79, 560–568 (2016). · DOI
  62. van Charante, E. P. et al. Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (PREDIVA): a cluster-randomised controlled trial. Lancet 388, 797–805 (2016). · DOI · Paper page
  63. Badhiwala, J. H. et al. Endovascular thrombectomy for acute ischemic stroke: a meta-analysis. JAMA 314, 1832–1843 (2015). · DOI · Paper page
  64. Parsons, M. W. et al. Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke. Ann. Neurol. 51, 28–37 (2002). · DOI · Paper page
  65. Wong, K. S. et al. Low-molecular-weight heparin compared with aspirin for the treatment of acute ischaemic stroke in asian patients with large artery occlusive disease: a randomised study. Lancet Neurol. 6, 407–413 (2007). · DOI
  66. Bath, P. M. & Wardlaw, J. M. Pharmacological treatment and prevention of cerebral small vessel disease: a review of potential interventions. Int. J. Stroke 10, 469–478 (2015). · DOI · Paper page
  67. Schmidt, R. et al. White matter lesion progression in LADIS: frequency, clinical effects, and sample size calculations. Stroke 43, 2643–2647 (2012). · DOI
  68. Markus, H. S. et al. Differences in stroke subtypes between black and white patients with stroke: the South London Ethnicity and Stroke study. Circulation 116, 2157–2164 (2007). · DOI
  69. Mok, V. C. et al. Long-term prognosis of Chinese patients with a lacunar infarct associated with small vessel disease: a five-year longitudinal study. Int. J. Stroke 4, 81–88 (2009). · DOI
  70. Mok, V. C. et al. Cognitive impairment and functional outcome after stroke associated with small vessel disease. J. Neurol. Neurosurg. Psychiatry 75, 560–566 (2004). · DOI · Paper page
  71. Sibolt, G. et al. White matter lesions are associated with hospital admissions because of hip-fractures and trauma after ischemic stroke. Stroke 45, 2948–2951 (2014). · DOI
  72. Alagiakrishnan, K., Hsueh, J., Zhang, E., Khan, K. & Senthilselvan, A. Small vessel disease/white matter disease of the brain and its association with osteoporosis. J. Clin. Med. Res. 7, 297–302 (2015). · DOI
  73. Brookes, R. L., Willis, T. A., Patel, B., Morris, R. G. & Markus, H. S. Depressive symptoms as a predictor of quality of life in cerebral small vessel disease, acting independently of disability; a study in both sporadic small vessel disease and cadasil. Int. J. Stroke 8, 510–517 (2013). · DOI
  74. van Sloten, T. T. et al. Cerebral small vessel disease and association with higher incidence of depressive symptoms in a general elderly population: the Ages-Reykjavik study. Am. J. Psychiatry 172, 570–578 (2015). · DOI
  75. Khan, U., Porteous, L., Hassan, A. & Markus, H. S. Risk factor profile of cerebral small vessel disease and its subtypes. J. Neurol. Neurosurg. Psychiatry 78, 702–706 (2007). · DOI · Paper page
  76. Hassan, A. et al. Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain 127, 212–219 (2004). · DOI · Paper page
  77. Choi, J. C. Genetics of cerebral small vessel disease. J. Stroke 17, 7–16 (2015). · DOI
  78. Rutten-Jacobs, L. C. et al. Association of MTHFR C677T genotype with ischemic stroke is confined to cerebral small vessel disease subtype. Stroke 47, 646–651 (2016). · DOI
  79. Reyahi, A. et al. Foxf2 is required for brain pericyte differentiation and development and maintenance of the blood-brain barrier. Dev. Cell 34, 19–32 (2015). · DOI · Paper page
  80. Joutel, A., Haddad, I., Ratelade, J. & Nelson, M. T. Perturbations of the cerebrovascular matrisome: a convergent mechanism in small vessel disease of the brain? J. Cereb. Blood Flow Metab. 36, 143–157 (2016). · DOI
  81. Tan, R. Y. & Markus, H. S. Monogenic causes of stroke: now and the future. J. Neurol. 262, 2601–2616 (2015). · DOI
  82. Rannikmäe, K. et al. Common variation in COL4A1/COL4A2 is associated with sporadic cerebral small vessel disease. Neurology 84, 918–926 (2015). · DOI
  83. Mok, V. & Kim, J. S. Prevention and management of cerebral small vessel disease. J. Stroke 17, 111–122 (2015). · DOI
  84. Xiong, Y. et al. Prestroke statins, progression of white matter hyperintensities, and cognitive decline in stroke patients with confluent white matter hyperintensities. Neurotherapeutics 11, 606–611 (2014). · DOI
  85. Mok, V. C. T. et al. Effects of statins on the progression of cerebral white matter lesion. J. Neurol. 256, 750–757 (2009). · DOI
  86. De Silva, T. M. & Miller, A. A. Cerebral small vessel disease: targeting oxidative stress as a novel therapeutic strategy? Front. Pharmacol. 7, 61 (2016). · DOI
  87. Benjamin, P. et al. Progression of MRI markers in cerebral small vessel disease: sample size considerations for clinical trials. J. Cereb. Blood Flow Metab. 36, 228–240 (2016). · DOI
  88. Schmidt, R. et al. White matter lesion progression: a surrogate endpoInt for trials in cerebral small-vessel disease. Neurology 63, 139–144 (2004). · DOI · Paper page
  89. Gulyas, B. et al. Visualising neuroinflammation in post-stroke patients: a comparative PET study with the TSPO molecular imaging biomarkers [11C]PK11195 and [11C]vinpocetine. Curr. Radiopharm. 5, 19–28 (2012). · DOI
  90. Hassan, A. et al. Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain 126, 424–432 (2003). · DOI · Paper page
  91. Poggesi, A., Pasi, M., Pescini, F., Pantoni, L. & Inzitari, D. Circulating biologic markers of endothelial dysfunction in cerebral small vessel disease: a review. J. Cereb. Blood Flow Metab. 36, 72–94 (2016). · DOI · Paper page
  92. De Guio, F. et al. Reproducibility and variability of quantitative magnetic resonance imaging markers in cerebral small vessel disease. J. Cereb. Blood Flow Metab. 36, 1319–1337 (2016). · DOI
  93. Wong, A. et al. The Ninds-Canadian stroke network vascular cognitive impairment neuropsychology protocols in Chinese. J. Neurol. Neurosurg. Psychiatry 84, 499–504 (2013). · DOI
  94. VITATOPS Trial Study Group. Vitamins in patients with recent transient ischaemic attack or stroke in the Vitamins to Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial. Lancet Neurol. 9, 855–865 (2010). · DOI · Paper page
  95. Cavalieri, M. et al. B vitamins and magnetic resonance imaging–detected ischemic brain lesions in patients with recent transient ischemic attack or stroke the Vitamins to Prevent Stroke (VITATOPS) MRI-substudy. Stroke 43, 3266–3270 (2012). · DOI

Cited by

See all 158

Metadata

Authors
Mok, V. C. T., Lam, B. Y. K., Wong, A., Ko, H., Markus, H. S., & Wong, L. K. S.
Venue
Nature Reviews Neurology
Publisher
Springer Science and Business Media LLC
Published
2017-02-17
Volume
13
Issue
3
Pages
148-159
ISSN
  • 1759-4758 (ISSN-L)
  • 1759-4766
DOI
10.1038/nrneurol.2017.16
OpenAlex
W2589102342
Cited by
158
References
34
FWCI
2.18
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Early-onset and delayed-onset poststroke dementia — revisiting the mechanisms. https://app.cochat.ai/papers/10.1038/nrneurol.2017.16
The paper
Mok, V. C. T., Lam, B. Y. K., Wong, A., Ko, H., Markus, H. S., & Wong, L. K. S. (2017). Early-onset and delayed-onset poststroke dementia — revisiting the mechanisms. Nature Reviews Neurology. https://doi.org/10.1038/nrneurol.2017.16

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.